439 related articles for article (PubMed ID: 21925189)
1. Dopamine D2 and serotonin 5-HT1A receptors mediate the actions of aripiprazole in mesocortical and mesoaccumbens transmission.
Tanahashi S; Yamamura S; Nakagawa M; Motomura E; Okada M
Neuropharmacology; 2012 Feb; 62(2):765-74. PubMed ID: 21925189
[TBL] [Abstract][Full Text] [Related]
2. In vivo actions of aripiprazole on serotonergic and dopaminergic systems in rodent brain.
Bortolozzi A; Díaz-Mataix L; Toth M; Celada P; Artigas F
Psychopharmacology (Berl); 2007 Apr; 191(3):745-58. PubMed ID: 17265076
[TBL] [Abstract][Full Text] [Related]
3. Aripiprazole, a novel antipsychotic drug, preferentially increases dopamine release in the prefrontal cortex and hippocampus in rat brain.
Li Z; Ichikawa J; Dai J; Meltzer HY
Eur J Pharmacol; 2004 Jun; 493(1-3):75-83. PubMed ID: 15189766
[TBL] [Abstract][Full Text] [Related]
4. Stress-induced activation of ventral tegmental mu-opioid receptors reduces accumbens dopamine tone by enhancing dopamine transmission in the medial pre-frontal cortex.
Latagliata EC; Valzania A; Pascucci T; Campus P; Cabib S; Puglisi-Allegra S
Psychopharmacology (Berl); 2014 Oct; 231(21):4099-108. PubMed ID: 24958228
[TBL] [Abstract][Full Text] [Related]
5. Opposite control of mesocortical and mesoaccumbal dopamine pathways by serotonin
Devroye C; Haddjeri N; Cathala A; Rovera R; Drago F; Piazza PV; Artigas F; Spampinato U
Neuropharmacology; 2017 Jun; 119():91-99. PubMed ID: 28390892
[TBL] [Abstract][Full Text] [Related]
6. Involvement of GABAA receptors in 5-HT1A and σ1 receptor synergism on prefrontal dopaminergic transmission under circulating neurosteroid deficiency.
Ago Y; Hasebe S; Hiramatsu N; Mori K; Watabe Y; Onaka Y; Hashimoto H; Takuma K; Matsuda T
Psychopharmacology (Berl); 2016 Sep; 233(17):3125-34. PubMed ID: 27339616
[TBL] [Abstract][Full Text] [Related]
7. Novel δ1-receptor agonist KNT-127 increases the release of dopamine and L-glutamate in the striatum, nucleus accumbens and median pre-frontal cortex.
Tanahashi S; Ueda Y; Nakajima A; Yamamura S; Nagase H; Okada M
Neuropharmacology; 2012 Apr; 62(5-6):2057-67. PubMed ID: 22266218
[TBL] [Abstract][Full Text] [Related]
8. Evidence for a differential medial prefrontal dopamine D1 and D2 receptor regulation of local and ventral tegmental glutamate and GABA release: a dual probe microdialysis study in the awake rat.
Harte M; O'Connor WT
Brain Res; 2004 Aug; 1017(1-2):120-9. PubMed ID: 15261107
[TBL] [Abstract][Full Text] [Related]
9. Involvement of 5-HT1A receptors in prefrontal cortex in the modulation of dopaminergic activity: role in atypical antipsychotic action.
Díaz-Mataix L; Scorza MC; Bortolozzi A; Toth M; Celada P; Artigas F
J Neurosci; 2005 Nov; 25(47):10831-43. PubMed ID: 16306396
[TBL] [Abstract][Full Text] [Related]
10. ACP-103, a 5-HT2A/2C inverse agonist, potentiates haloperidol-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens.
Li Z; Ichikawa J; Huang M; Prus AJ; Dai J; Meltzer HY
Psychopharmacology (Berl); 2005 Dec; 183(2):144-53. PubMed ID: 16220333
[TBL] [Abstract][Full Text] [Related]
11. Aripiprazole differentially affects mesolimbic and nigrostriatal dopaminergic transmission: implications for long-term drug efficacy and low extrapyramidal side-effects.
Han M; Huang XF; Deng C
Int J Neuropsychopharmacol; 2009 Aug; 12(7):941-52. PubMed ID: 19203411
[TBL] [Abstract][Full Text] [Related]
12. F15063, a potential antipsychotic with dopamine D2/D3 receptor antagonist, 5-HT1A receptor agonist and dopamine D4 receptor partial agonist properties: influence on neuronal firing and neurotransmitter release.
Assié MB; Mnie-Filali O; Ravailhe V; Benas C; Marien M; Bétry C; Zimmer L; Haddjeri N; Newman-Tancredi A
Eur J Pharmacol; 2009 Apr; 607(1-3):74-83. PubMed ID: 19326477
[TBL] [Abstract][Full Text] [Related]
13. Effects of antipsychotic drugs on extracellular dopamine levels in rat medial prefrontal cortex and nucleus accumbens.
Kuroki T; Meltzer HY; Ichikawa J
J Pharmacol Exp Ther; 1999 Feb; 288(2):774-81. PubMed ID: 9918588
[TBL] [Abstract][Full Text] [Related]
14. Asenapine increases dopamine, norepinephrine, and acetylcholine efflux in the rat medial prefrontal cortex and hippocampus.
Huang M; Li Z; Dai J; Shahid M; Wong EH; Meltzer HY
Neuropsychopharmacology; 2008 Nov; 33(12):2934-45. PubMed ID: 18418367
[TBL] [Abstract][Full Text] [Related]
15. 5-HT6 receptor antagonist SB-399885 potentiates haloperidol and risperidone-induced dopamine efflux in the medial prefrontal cortex or hippocampus.
Li Z; Huang M; Prus AJ; Dai J; Meltzer HY
Brain Res; 2007 Feb; 1134(1):70-8. PubMed ID: 17207474
[TBL] [Abstract][Full Text] [Related]
16. Basolateral amygdala modulation of the nucleus accumbens dopamine response to stress: role of the medial prefrontal cortex.
Stevenson CW; Gratton A
Eur J Neurosci; 2003 Mar; 17(6):1287-95. PubMed ID: 12670317
[TBL] [Abstract][Full Text] [Related]
17. Selective enhancement of mesocortical dopaminergic transmission by noradrenergic drugs: therapeutic opportunities in schizophrenia.
Masana M; Bortolozzi A; Artigas F
Int J Neuropsychopharmacol; 2011 Feb; 14(1):53-68. PubMed ID: 20701825
[TBL] [Abstract][Full Text] [Related]
18. The reinforcing effects of ethanol within the posterior ventral tegmental area depend on dopamine neurotransmission to forebrain cortico-limbic systems.
Ding ZM; Ingraham CM; Rodd ZA; McBride WJ
Addict Biol; 2015 May; 20(3):458-68. PubMed ID: 24674134
[TBL] [Abstract][Full Text] [Related]
19. Effects of cariprazine on extracellular levels of glutamate, GABA, dopamine, noradrenaline and serotonin in the medial prefrontal cortex in the rat phencyclidine model of schizophrenia studied by microdialysis and simultaneous recordings of locomotor activity.
Kehr J; Yoshitake T; Ichinose F; Yoshitake S; Kiss B; Gyertyán I; Adham N
Psychopharmacology (Berl); 2018 May; 235(5):1593-1607. PubMed ID: 29637288
[TBL] [Abstract][Full Text] [Related]
20. Expression of 5-HT2A receptors in prefrontal cortex pyramidal neurons projecting to nucleus accumbens. Potential relevance for atypical antipsychotic action.
Mocci G; Jiménez-Sánchez L; Adell A; Cortés R; Artigas F
Neuropharmacology; 2014 Apr; 79():49-58. PubMed ID: 24211653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
